Tags

Type your tag names separated by a space and hit enter

Prevalence of erectile dysfunction in patients with metabolic syndrome.
Int J Urol 2006; 13(4):385-8IJ

Abstract

AIM

We wished to investigate the relationship between metabolic syndrome and erectile dysfunction (ED).

MATERIALS AND METHODS

A total of 268 patients were included in this study. All of the patients were asked to fill in an International Index for Erectile Function (IIEF) questionnaire. The presence of metabolic syndrome was determined when any three or more of the five risk factors were present according to the National Cholesterol Education Program (NCEP) Adult Treatment Panel (ATP)-III. The relationship between risk factor for metabolic syndrome and ED status was determined according to logistic regression analysis.

RESULTS

Eighty-nine patients (33%) constituted the metabolic syndrome group. IIEF-EF domain scores of patients with and without metabolic syndrome were 17.7 +/- 7.9 and 21.7 +/- 7.5, respectively (P < 0.001). Seventy-four percent of patients with metabolic syndrome and 50% of patients without metabolic syndrome had ED (P < 0.001; odds ratio 2.9; 95% CI 1.7-5.0). Erectile function domain scores significantly decreased as the number of metabolic risk factors increased (P < 0.001). Patients with the risk factor of fasting blood glucose (FBG), waist circumference (WC), or hypertension (HT) had lower erectile function domain scores than the patients with other metabolic risk factors. Logistic regression analysis revealed that FBG and WC were the most important criteria for ED.

CONCLUSIONS

Metabolic syndrome seems to be a potential risk factor for ED. We recommend patients with metabolic syndrome should be questioned about ED, and WC measurement might take part in the evaluation of ED.

Authors+Show Affiliations

Dokuz Eylul University Medical School, Inciralti, Izmir, Turkey. tevfikalper@yahoo.comNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Comparative Study
Journal Article

Language

eng

PubMed ID

16734855

Citation

Demir, Tevfik, et al. "Prevalence of Erectile Dysfunction in Patients With Metabolic Syndrome." International Journal of Urology : Official Journal of the Japanese Urological Association, vol. 13, no. 4, 2006, pp. 385-8.
Demir T, Demir O, Kefi A, et al. Prevalence of erectile dysfunction in patients with metabolic syndrome. Int J Urol. 2006;13(4):385-8.
Demir, T., Demir, O., Kefi, A., Comlekci, A., Yesil, S., & Esen, A. (2006). Prevalence of erectile dysfunction in patients with metabolic syndrome. International Journal of Urology : Official Journal of the Japanese Urological Association, 13(4), pp. 385-8.
Demir T, et al. Prevalence of Erectile Dysfunction in Patients With Metabolic Syndrome. Int J Urol. 2006;13(4):385-8. PubMed PMID: 16734855.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Prevalence of erectile dysfunction in patients with metabolic syndrome. AU - Demir,Tevfik, AU - Demir,Omer, AU - Kefi,Aykut, AU - Comlekci,Abdurrahman, AU - Yesil,Sena, AU - Esen,Adil, PY - 2006/6/1/pubmed PY - 2006/10/25/medline PY - 2006/6/1/entrez SP - 385 EP - 8 JF - International journal of urology : official journal of the Japanese Urological Association JO - Int. J. Urol. VL - 13 IS - 4 N2 - AIM: We wished to investigate the relationship between metabolic syndrome and erectile dysfunction (ED). MATERIALS AND METHODS: A total of 268 patients were included in this study. All of the patients were asked to fill in an International Index for Erectile Function (IIEF) questionnaire. The presence of metabolic syndrome was determined when any three or more of the five risk factors were present according to the National Cholesterol Education Program (NCEP) Adult Treatment Panel (ATP)-III. The relationship between risk factor for metabolic syndrome and ED status was determined according to logistic regression analysis. RESULTS: Eighty-nine patients (33%) constituted the metabolic syndrome group. IIEF-EF domain scores of patients with and without metabolic syndrome were 17.7 +/- 7.9 and 21.7 +/- 7.5, respectively (P < 0.001). Seventy-four percent of patients with metabolic syndrome and 50% of patients without metabolic syndrome had ED (P < 0.001; odds ratio 2.9; 95% CI 1.7-5.0). Erectile function domain scores significantly decreased as the number of metabolic risk factors increased (P < 0.001). Patients with the risk factor of fasting blood glucose (FBG), waist circumference (WC), or hypertension (HT) had lower erectile function domain scores than the patients with other metabolic risk factors. Logistic regression analysis revealed that FBG and WC were the most important criteria for ED. CONCLUSIONS: Metabolic syndrome seems to be a potential risk factor for ED. We recommend patients with metabolic syndrome should be questioned about ED, and WC measurement might take part in the evaluation of ED. SN - 0919-8172 UR - https://www.unboundmedicine.com/medline/citation/16734855/Prevalence_of_erectile_dysfunction_in_patients_with_metabolic_syndrome_ L2 - https://doi.org/10.1111/j.1442-2042.2006.01310.x DB - PRIME DP - Unbound Medicine ER -